PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Chlorhexidine→

Chlorhexidine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
55-56-1
Molecular formula
C22H30Cl2N10
Molecular weight
505.4 g/mol
Drug class
Bisbiguanide antiseptictopical membrane-disrupting antimicrobial
Mechanism of action
Interacts with negatively charged microbial cell membranes and cell-wall components, increasing membrane permeability and causing leakage of intracellular contents. At higher concentrations it produces precipitation of cytoplasmic components and cell death.
Indications / reported uses
  • Skin antisepsis and preparation of the skin before invasive procedures using authorised chlorhexidine products
  • Oral rinses for reduction of dental plaque and gingivitis as an adjunct to oral hygiene
  • Selected ophthalmic, wound-care, catheter and device antisepsis applications require route- and concentration-specific products; avoid ocular, middle-ear and neural tissue exposure

Sources: US DailyMed — Chlorhexidine gluconate products · NHS — Chlorhexidine · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Chlorhexidine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Chlorhexidine Permitted Daily Exposure (PDE) report (the Chlorhexidine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Chlorhexidine Occupational Exposure Limit (OEL) report (the Chlorhexidine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.